NCT05534386 A Self-management Based Survivorship Intervention for Chinese Cancer Survivors
| NCT ID | NCT05534386 |
| Status | Recruiting |
| Phase | — |
| Sponsor | The University of Hong Kong |
| Condition | Physical Symptom Distress |
| Study Type | INTERVENTIONAL |
| Enrollment | 486 participants |
| Start Date | 2023-04-12 |
| Primary Completion | 2026-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 486 participants in total. It began in 2023-04-12 with a primary completion date of 2026-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study, using a sequential multiple assessment randomized controlled trial (SMART) approach, will evaluate a cancer survivorship care intervention on physical symptom distress, weight management, self-efficacy in managing cancer and health-related quality of life among Chinese patients recently completed curative cancer treatment.
Eligibility Criteria
Inclusion Criteria: * Cantonese- or Mandarin-speaking Chinese patients diagnosed curable cancer * have completed primary and adjuvant treatment within the past six months Exclusion Criteria: * Patients diagnosed with metastatic cancer
Contact & Investigator
Wendy Wing Tak Lam, PhD
PRINCIPAL INVESTIGATOR
School of Public Health, The University of Hong Kong
Frequently Asked Questions
Who can join the NCT05534386 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Physical Symptom Distress. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05534386 currently recruiting?
Yes, NCT05534386 is actively recruiting participants. Contact the research team at wwtlam@hku.hk for enrollment information.
Where is the NCT05534386 trial being conducted?
This trial is being conducted at Hong Kong, Hong Kong, Hong Kong, Hong Kong, Hong Kong, Hong Kong, Hong Kong, Hong Kong and 3 additional locations.
Who is sponsoring the NCT05534386 clinical trial?
NCT05534386 is sponsored by The University of Hong Kong. The principal investigator is Wendy Wing Tak Lam, PhD at School of Public Health, The University of Hong Kong. The trial plans to enroll 486 participants.